InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Brown Ryan Edward, Vice-Président Senior, Conseiller Général. Director active across 1 companies, notably Sarepta Therapeutics, Inc.. Aggregated, 5 reports have been published. The latest transaction was disclosed on 1 June 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
€3,68354 shares@ €68.20810.0002% mcap3.5% of flow
Common Stock
SEC:0001209191-22-034380:0·
€81,2981,136 shares@ €71.56510.0036% mcap77.2% of flow
Common Stock
SEC:0001209191-22-017346:0·
€12,312184 shares@ €66.91380.0005% mcap11.7% of flow
Common Stock
SEC:0001209191-22-014407:0·
€3,98264 shares@ €62.2127100.0% of flow
Common Stock
SEC:0001209191-21-037727·
€3,98264 shares@ €62.21270.0002% mcap3.8% of flow
Common Stock
SEC:0001209191-21-037727:0·
5 of 5 declarations
About Brown Ryan Edward
Ryan Edward Brown serves as SVP, General Counsel at Sarepta Therapeutics, Inc. He oversees the legal affairs of the company, ensuring compliance with regulations and laws. His role is essential in protecting the interests of Sarepta Therapeutics, Inc. and supporting strategic decision-making. Brown is committed to promoting legal best practices within the organization.
